Abstract
Introduction
As medication adherence continues to be a prevalent issue in today’s society, the methods used to monitor medication-taking behaviors are constantly being re-evaluated and compared in search of the ‘gold standard’ measure. Our review aimed to assess the current literature surrounding the correlation between self-reported questionnaires (SRQs) and electronic monitoring devices to determine if these measures produce similar results.
Methods
We performed a literature search from 2009 to 2017 using PubMed, PubMed In-Process and Non-Indexed, EMBASE, Ovid MEDLINE, and Ovid MEDLINE In-Process. A keyword search using the terms ‘patient compliance’, ‘treatment compliance’, ‘medication adherence’, ‘drug monitoring’, ‘drug therapy’, ‘electronic’, ‘digital’, ‘computer’, ‘monitor’, ‘monitoring’, ‘drug’, ‘pharmaceutical preparations’, ‘compliance’, and ‘medications’ was done to capture all articles. We included articles measuring adherence using both monitoring devices and SRQs.
Results
Thirty-five articles were included in this review. The average difference in measured adherence rates between the two measures was 9.2% (range −66.3 to 61.5). A majority (62.7%) of articles reported moderate (n = 12; 27.9%), high (n = 5, 11.6%), or significant (n = 10, 23.3%) correlations between SRQs and monitoring devices.
Conclusion
Results from our review are consistent with previous studies, as we found that many of our studies produced moderate to high correlation between both SRQs and monitoring devices [Farmer, Clin Ther 21(6):1074–90 (1999), IMS Institute for Healthcare Informatics. Avoidable costs in US health care (2012), Patel et al., Respirology 18(3):546–52 (2013), Siracusa et al., J Cyst Fibros 14(5):621–6 (2015), Smith et al., Int J Cardiol 145(1):122–3 (2010)]. Our findings demonstrate that self-reported adherence produces comparable results to electronic monitoring devices. As there is not yet a ‘gold standard’ measure for monitoring patient adherence, SRQs and Medication Event Monitoring Systems (MEMS) operating together continue to emerge as the preferred effective method for measuring medication adherence.
Similar content being viewed by others
References
Brown MT, Bussell JK. Medication adherence: WHO cares? Mayo Clin Proc. 2011;86(4):304–14. doi:10.4065/mcp.2010.0575.
Hugtenburg JG, Timmers L, Elders PJ, Vervloet M, van Dijk L. Definitions, variants, and causes of nonadherence with medication: a challenge for tailored interventions. Patient Prefer Adher. 2013;7:675–82. doi:10.2147/PPA.S29549.
Osterberg L, Blaschke T. Adherence to medication. N Engl J Med. 2005;353(5):487–97. doi:10.1056/NEJMra050100.
Bosworth HB, Granger BB, Mendys P, Brindis R, Burkholder R, Czajkowski SM, Granger CB. Medication adherence: a call for action. Am Heart J. 2011;162(3):412–24. doi:10.1016/j.ahj.2011.06.007.
Iuga AO, McGuire MJ. Adherence and health care costs. Risk Manag Healthc Policy. 2014;7:35–44. doi:10.2147/RMHP.S19801.
De Geest S, Sabate E. Adherence to long-term therapies: evidence for action. Eur J Cardiovasc Nurs. 2003;2(4):323. doi:10.1016/S1474-5151(03)00091-4.
Farmer KC. Methods for measuring and monitoring medication regimen adherence in clinical trials and clinical practice. Clin Ther. 1999;21(6):1074–90. doi:10.1016/S0149-2918(99)80026-5 (discussion 1073).
Lam WY, Fresco P. Medication adherence measures: an overview. Biomed Res Int. 2015;2015:217047. doi:10.1155/2015/217047.
Williams AB, Amico KR, Bova C, Womack JA. A proposal for quality standards for measuring medication adherence in research. AIDS Behav. 2013;17(1):284–97. doi:10.1007/s10461-012-0172-7.
Velligan DI, Wang M, Diamond P, Glahn DC, Castillo D, Bendle S, Miller AL. Relationships among subjective and objective measures of adherence to oral antipsychotic medications. Psychiatr Serv. 2007;58(9):1187–92. doi:10.1176/ps.2007.58.9.1187.
Dew MA, Dabbs AD, Myaskovsky L, Shyu S, Shellmer DA, DiMartini AF, Greenhouse JB. Meta-analysis of medical regimen adherence outcomes in pediatric solid organ transplantation. Transplantation. 2009;88(5):736–46. doi:10.1097/TP.0b013e3181b2a0e0.
Clifford S, Perez-Nieves M, Skalicky AM, Reaney M, Coyne KS. A systematic literature review of methodologies used to assess medication adherence in patients with diabetes. Curr Med Res Opin. 2014;30(6):1071–85. doi:10.1185/03007995.2014.884491.
Shi L, Liu J, Koleva Y, Fonseca V, Kalsekar A, Pawaskar M. Concordance of adherence measurement using self-reported adherence questionnaires and medication monitoring devices. Pharmacoeconomics. 2010;28(12):1097–107. doi:10.2165/11537400-000000000-00000.
Quality of Reporting of Meta-Analyses (QUOROM). (2008). https://www.biomedcentral.com/content/supplementary/1471-2261-10-24-s1.pdf. Accessed 24 Oct 2014.
Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA). PRISMA 27-item Systematic Review and Meta-Analyses checklist. Transparent Reporting of Systematic Reviews and Meta-Analyses (2009). http://prisma-statement.org/PRISMAStatement/Checklist.aspx. Accessed 2 Jan 2015.
Yang J, Ko YH, Paik JW, Lee MS, Han C, Joe SH, Kim SH. Symptom severity and attitudes toward medication: impacts on adherence in outpatients with schizophrenia. Schizophr Res. 2012;134(2–3):226–31. doi:10.1016/j.schres.2011.11.008.
IMS Institute for Healthcare Informatics. Avoidable costs in US health care. 2013. Available at: http://www.imshealth.com/deployedles/imshealth/Global/Content/Corporate/IMS%20Institute/RUOM-2013/IHII_Responsible_Use_Medicines_2013.pdf. Accessed 10 Sept 2013.
Benjamin RM. Medication adherence: helping patients take their medicines as directed. Public Health Rep. 2012;127(1):2–3.
Cook PF, Schmiege SJ, Mansberger SL, Kammer J, Fitzgerald T, Kahook MY. Predictors of adherence to glaucoma treatment in a multisite study. Ann Behav Med. 2015;49(1):29–39. doi:10.1007/s12160-014-9641-8.
Garber MC, Nau DP, Erickson SR, et al. The concordance of self-report with other measures of medication adherence: a summary of the literature. Med Care. 2004;42(7):649–52.
Wang P, Benner JS, Glynn RJ, et al. How well do patients report noncompliance with antihypertensive medications? A comparison of self-report versus filled prescriptions. Pharmacoepidemiol Drug Saf. 2004;13(1):11–9.
Barnestein-Fonseca P, Leiva-Fernandez J, Vidal-Espana F, Garcia-Ruiz A, Prados-Torres D, Leiva-Fernandez F. Is it possible to diagnose the therapeutic adherence of patients with COPD in clinical practice? A cohort study. BMC Pulm Med. 2011;11:6. doi:10.1186/1471-2466-11-6.
Badiee J, Riggs PK, Rooney AS, Vaida F, Grant I, Atkinson JH, Hiv Neurobehavioral Research Program, G. Approaches to identifying appropriate medication adherence assessments for HIV infected individuals with comorbid bipolar disorder. AIDS Patient Care STDS. 2012;26(7):388–94. doi:10.1089/apc.2011.0447.
Van den Boogaard J, Lyimo RA, Boeree MJ, Kibiki GS, Aarnoutse RE. Electronic monitoring of treatment adherence and validation of alternative adherence measures in tuberculosis patients: a pilot study. Bull World Health Organ. 2011;89(9):632–9. doi:10.2471/BLT.11.086462.
Wickstrom G, Bendix T. The ‘Hawthorne effect’: what did the original Hawthorne studies actually show? Scand J Work Environ Health. 2000;26(4):363–7.
Feinstein AR. On white-coat effects and the electronic monitoring of compliance. Arch Intern Med. 1990;150(7):1377–8.
Chesney MA, Ickovics JR, Chambers DB, Gifford AL, Neidig J, Zwickl B, Wu AW. Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: the AACTG adherence instruments. Patient Care Committee and Adherence Working Group of the Outcomes Committee of the Adult AIDS Clinical Trials Group (AACTG). AIDS Care. 2000;12(3):255–66.
Doro P, Benko R, Czako A, Matuz M, Thurzo F, Soos G. Optimal recall period in assessing the adherence to antihypertensive therapy: a pilot study. Int J Clin Pharm. 2011;33(4):690–5. doi:10.1007/s11096-011-9529-7.
Cate H, Bhattacharya D, Clark A, Holland R, Broadway DC. A comparison of measures used to describe adherence to glaucoma medication in a randomised controlled trial. Clin Trials. 2015;12(6):608–17. doi:10.1177/1740774515592636.
Ayoade A, Oladipo I. Evaluation of the correlation between self-report and electronic monitoring of adherence to hypertension therapy. Blood Press. 2012;21(3):161–6. doi:10.3109/08037051.2012.679029.
Dunn KE, King VL, Brooner RK. Comparison of methods to assess psychiatric medication adherence in methadone-maintained patients with co-occurring psychiatric disorder. Drug Alcohol Depend. 2016;160:212–7. doi:10.1016/j.drugalcdep.2016.01.016.
Dunbar-Jacob J, Sereika SM, Houze M, Luyster FS, Callan JA. Accuracy of measures of medication adherence in a cholesterol-lowering regimen. West J Nurs Res. 2012;34(5):578–97. doi:10.1177/0193945912439251.
Cate H, Bhattacharya D, Clark A, Holland R, Broadway DC. Patterns of adherence behaviour for patients with glaucoma. Eye (Lond). 2013;27(4):545–53. doi:10.1038/eye.2012.294.
Sayner R, Carpenter DM, Blalock SJ, Robin AL, Muir KW, Hartnett ME, Sleath B. Accuracy of patient-reported adherence to glaucoma medications on a visual analog scale compared with electronic monitors. Clin Ther. 2015;37(9):1975–85. doi:10.1016/j.clinthera.2015.06.008.
Price DD, Staud R, Robinson ME, et al. How should we use the visual analogue scale (VAS) in rehabilitation outcomes? II: Visual analogue scales as ratio scales: an alternative to the view of Kersten et al. J Rehabil Med. 2012;44(9):800–4. doi:10.2340/16501977-1031.
Buscher A, Hartman C, Kallen MA, Giordano TP. Validity of self-report measures in assessing antiretroviral adherence of newly diagnosed, HAART-naive, HIV patients. HIV Clin Trials. 2011;12(5):244–54. doi:10.1310/hct1205-244.
De Cuyper E, De Gucht V, Maes S, Van Camp Y, De Clerck LS. Determinants of methotrexate adherence in rheumatoid arthritis patients. Clin Rheumatol. 2016;35(5):1335–9. doi:10.1007/s10067-016-3182-4.
Svarstad BL, Chewning BA, Sleath BL, Claesson C. The Brief Medication Questionnaire: a tool for screening patient adherence and barriers to adherence. Patient Educ Couns. 1999;37(2):113–24.
Bogner HR, de Vries HF, O’’onnell AJ, Morales KH. Measuring concurrent oral hypoglycemic and antidepressant adherence and clinical outcomes. Am J Manag Care. 2013;19(3):e85–92.
Applebaum AJ, Reilly LC, Gonzalez JS, Richardson MA, Leveroni CL, Safren SA. The impact of neuropsychological functioning on adherence to HAART in HIV-infected substance abuse patients. AIDS Patient Care STDS. 2009;23(6):455–62. doi:10.1089/apc.2008.0181.
Bruxvoort K, Festo C, Cairns M, Kalolella A, Mayaya F, Kachur SP, Goodman C. Measuring patient adherence to malaria treatment: a comparison of results from self-report and a customised electronic monitoring device. PLoS One. 2015;10(7):e0134275. doi:10.1371/journal.pone.0134275.
Christensen A, Christrup LL, Fabricius PE, Chrostowska M, Wronka M, Narkiewicz K, Hansen EH. The impact of an electronic monitoring and reminder device on patient compliance with antihypertensive therapy: a randomized controlled trial. J Hypertens. 2010;28(1):194–200. doi:10.1097/HJH.0b013e328331b718.
Das M, Santos D, Matheson T, Santos GM, Chu P, Vittinghoff E, Colfax GN. Feasibility and acceptability of a phase II randomized pharmacologic intervention for methamphetamine dependence in high-risk men who have sex with men. AIDS. 2010;24(7):991–1000.
Eberlin M, Otto G, Kramer I. Increased medication compliance of liver transplant patients switched from a twice-daily to a once-daily tacrolimus-based immunosuppressive regimen. Transplant Proc. 2013;45(6):2314–20. doi:10.1016/j.transproceed.2012.10.037.
Gillespie D, Hood K, Farewell D, Stenson R, Probert C, Hawthorne AB. Electronic monitoring of medication adherence in a 1-year clinical study of 2 dosing regimens of mesalazine for adults in remission with ulcerative colitis. Inflamm Bowel Dis. 2014;20(1):82–91. doi:10.1097/01.MIB.0000437500.60546.2a.
Greenley RN, Kunz JH, Biank V, Martinez A, Miranda A, Noe J, Stephens MC. Identifying youth nonadherence in clinical settings: data-based recommendations for children and adolescents with inflammatory bowel disease. Inflamm Bowel Dis. 2012;18(7):1254–9. doi:10.1002/ibd.21859.
Inauen J, Bierbauer W, Luscher J, Konig C, Tobias R, Ihle A, Scholz U. Assessing adherence to multiple medications and in daily life among patients with multimorbidity. Psychol Health. 2017;. doi:10.1080/08870446.2016.1275632.
Jentzsch NS, Camargos PA, Colosimo EA, Bousquet J. Monitoring adherence to beclomethasone in asthmatic children and adolescents through four different methods. Allergy. 2009;64(10):1458–62. doi:10.1111/j.1398-9995.2009.02037.x.
Kennedy AP, Epstein DH, Jobes ML, Agage D, Tyburski M, Phillips KA, Preston KL. Continuous in-the-field measurement of heart rate: correlates of drug use, craving, stress, and mood in polydrug users. Drug Alcohol Depend. 2015;151:159–66. doi:10.1016/j.drugalcdep.2015.03.024.
Modi AC, Zeller MH, Xanthakos SA, Jenkins TM, Inge TH. Adherence to vitamin supplementation following adolescent bariatric surgery. Obesity (Silver Spring). 2013;21(3):E190–5. doi:10.1002/oby.20031.
Waimann CA, Marengo MF, de Achaval S, Cox VL, Garcia-Gonzalez A, Reveille JD, Suarez-Almazor ME. Electronic monitoring of oral therapies in ethnically diverse and economically disadvantaged patients with rheumatoid arthritis: consequences of low adherence. Arthritis Rheum. 2013;65(6):1421–9. doi:10.1002/art.37917.
Pai AL, Rausch J, Tackett A, Marsolo K, Drotar D, Goebel J. System for integrated adherence monitoring: real-time non-adherence risk assessment in pediatric kidney transplantation. Pediatr Transplant. 2012;16(4):329–34. doi:10.1111/j.1399-3046.2012.01657.x.
Okeke CO, Quigley HA, Jampel HD, Ying GS, Plyler RJ, Jiang Y, Friedman DS. Adherence with topical glaucoma medication monitored electronically the Travatan Dosing Aid study. Ophthalmology. 2009;116(2):191–9. doi:10.1016/j.ophtha.2008.09.004.
Patel M, Perrin K, Pritchard A, Williams M, Wijesinghe M, Weatherall M, Beasley R. Accuracy of patient self-report as a measure of inhaled asthma medication use. Respirology. 2013;18(3):546–52. doi:10.1111/resp.12059.
Van Camp YP, Vrijens B, Abraham I, Van Rompaey B, Elseviers MM. Adherence to phosphate binders in hemodialysis patients: prevalence and determinants. J Nephrol. 2014;27(6):673–9. doi:10.1007/s40620-014-0062-3.
Wiens MO, MacLeod S, Musiime V, Ssenyonga M, Kizza R, Bakeera-Kitaka S, Ssali F. Adherence to antiretroviral therapy in HIV-positive adolescents in Uganda assessed by multiple methods: a prospective cohort study. Paediatr Drugs. 2012;14(5):331–5. doi:10.2165/11599280-000000000-00000.
Smith H, Hankins M, Hodson A, George C. Measuring the adherence to medication of elderly patients with heart failure: is there a gold standard? Int J Cardiol. 2010;145(1):122–3. doi:10.1016/j.ijcard.2009.06.031.
Siracusa CM, Ryan J, Burns L, Wang Y, Zhang N, Clancy JP, Drotar D. Electronic monitoring reveals highly variable adherence patterns in patients prescribed ivacaftor. J Cyst Fibros. 2015;14(5):621–6. doi:10.1016/j.jcf.2015.05.009.
Sajatovic M, Levin JB, Sams J, Cassidy KA, Akagi K, Aebi ME, Tatsuoka C. Symptom severity, self-reported adherence, and electronic pill monitoring in poorly adherent patients with bipolar disorder. Bipolar Disord. 2015;17(6):653–61. doi:10.1111/bdi.12326.
Data Availability Statement
All data that support these findings can be found in each of the articles listed in Table 3. Additionally, for further information, each article included in this review is listed in the References section.
Author information
Authors and Affiliations
Contributions
The editor of PharmacoEconomics suggested the review. Alisha Monnette conducted the literature review, participated in the design, interpretation of the results, and led the writing of the manuscript. Yichen Zhang assisted the principal investigator with the literature search, performed the statistical analyses, and the interpretation of the results. Hui Shao participated in the analytical plan and interpretation of the results. Lizheng Shi was the consultant for the project and participated in the interpretation of the results and manuscript presentation. All authors contributed to the development of the manuscript and agreed on the final submitted version. The authors thank the editor and two anonymous reviewers for their constructive comments.
Corresponding author
Ethics declarations
Funding
No external funding was received.
Conflict of interest
No conflict exists for Alisha Monnette, Yichen Zhang, Hui Shao, or Lizheng Shi.
Ethical approval
For this type of study formal consent is not required.
Rights and permissions
About this article
Cite this article
Monnette, A., Zhang, Y., Shao, H. et al. Concordance of Adherence Measurement Using Self-Reported Adherence Questionnaires and Medication Monitoring Devices: An Updated Review. PharmacoEconomics 36, 17–27 (2018). https://doi.org/10.1007/s40273-017-0570-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40273-017-0570-9